5-90805341-G-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_032119.4(ADGRV1):c.14719G>T(p.Val4907Phe) variant causes a missense change. The variant allele was found at a frequency of 0.0000465 in 1,612,314 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V4907I) has been classified as Likely benign.
Frequency
Consequence
NM_032119.4 missense
Scores
Clinical Significance
Conservation
Publications
- Usher syndrome type 2Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Usher syndrome type 2CInheritance: AR Classification: STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- febrile seizures, familial, 4Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- nonsyndromic genetic hearing lossInheritance: AR Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_032119.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ADGRV1 | NM_032119.4 | MANE Select | c.14719G>T | p.Val4907Phe | missense | Exon 72 of 90 | NP_115495.3 | ||
| ADGRV1 | NR_003149.2 | n.14735G>T | non_coding_transcript_exon | Exon 72 of 90 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ADGRV1 | ENST00000405460.9 | TSL:1 MANE Select | c.14719G>T | p.Val4907Phe | missense | Exon 72 of 90 | ENSP00000384582.2 | ||
| ADGRV1 | ENST00000638510.1 | TSL:1 | n.1986G>T | non_coding_transcript_exon | Exon 8 of 26 | ||||
| ADGRV1 | ENST00000425867.3 | TSL:5 | c.3673G>T | p.Val1225Phe | missense | Exon 20 of 38 | ENSP00000392618.3 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152176Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000321 AC: 8AN: 248956 AF XY: 0.0000222 show subpopulations
GnomAD4 exome AF: 0.0000473 AC: 69AN: 1460138Hom.: 0 Cov.: 30 AF XY: 0.0000413 AC XY: 30AN XY: 726318 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74338 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.Val4907Phe variant in ADGRV1 has not been previously reported in individuals with hearing loss or Usher syndrome, but it has been identified in 0.007% (8/112882) European chromosomes by gnomAD (http://gnomad.broadinstitute.org). It has been reported in ClinVar (Variation ID 504584). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conservation analyses suggest that this variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, the clinical significance of the p.Val4907Phe variant is uncertain. ACMG/AMP Criteria applied: PM2, BP4.
Inborn genetic diseases Uncertain:1
The c.14719G>T (p.V4907F) alteration is located in exon 72 (coding exon 72) of the ADGRV1 gene. This alteration results from a G to T substitution at nucleotide position 14719, causing the valine (V) at amino acid position 4907 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Febrile seizures, familial, 4;C2931213:Usher syndrome type 2C Uncertain:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at